Stockscreener 앱 받기
187.85
1.29%
-2.46
시간 외 거래:
187.85
전일 마감가:
$190.31
열려 있는:
$191.38
하루 거래량:
1.26M
Relative Volume:
1.09
시가총액:
$26.62B
수익:
$2.31B
순이익/손실:
$-208.16M
주가수익비율:
-122.25
EPS:
-1.5366
순현금흐름:
$76.11M
1주 성능:
-5.19%
1개월 성능:
-8.91%
6개월 성능:
+11.48%
1년 성능:
+31.82%
1일 변동 폭
$187.01
$192.36
1주일 범위
$186.07
$207.08
52주 변동 폭
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
187.85 | 26.62B | 2.31B | -208.16M | 76.11M | -1.5366 |
|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | Citigroup | Buy |
| 2025-12-02 | 재개 | Morgan Stanley | Overweight |
| 2025-10-27 | 업그레이드 | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 재개 | Wells Fargo | Equal Weight |
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
Guidance Update: Can Natera Inc keep up with sector leadersPortfolio Gains Summary & AI Based Trade Execution Alerts - baoquankhu1.vn
Zenith Genomics Launch Could Be A Game Changer For Natera’s (NTRA) Rare Disease Strategy - Yahoo Finance
Natera Launches Zenith Genomics To Expand Rare Disease Testing Story - simplywall.st
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - Sahm
MyOme Debuts Zenithtm Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026 - lelezard.com
Natera launches whole genome sequencing test for rare diseases - Investing.com South Africa
[144] Natera, Inc. SEC Filing - Stock Titan
GeneDx stock falls as Natera launches competing rare disease test - Investing.com UK
GeneDx stock falls as Natera launches competing rare disease test By Investing.com - Investing.com Australia
Natera announces commercial launch of Zenith genomics - TipRanks
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis - BioSpace
Natera, Inc. $NTRA Shares Sold by Swiss National Bank - MarketBeat
New genome test from Natera and MyOme targets 5-year rare disease delays - Stock Titan
Natera, Inc. $NTRA Shares Bought by Franklin Resources Inc. - MarketBeat
Capital Fund Management S.A. Buys 41,307 Shares of Natera, Inc. $NTRA - MarketBeat
Natera: Daniel Rabinowitz sells $356k in shares - Investing.com Nigeria
Natera director Sheena Jonathan sells $25924 in stock - Investing.com
Natera president Fesko sells $144k in shares - Investing.com
Natera director Sheena Jonathan sells $25924 in stock By Investing.com - Investing.com India
Natera: Daniel Rabinowitz sells $356k in shares By Investing.com - Investing.com India
Natera president Fesko sells $144k in shares By Investing.com - Investing.com India
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 5,623 Shares of Stock - MarketBeat
Natera (NASDAQ:NTRA) Insider John Fesko Sells 707 Shares of Stock - MarketBeat
Michael Burkes Brophy Sells 785 Shares of Natera (NASDAQ:NTRA) Stock - MarketBeat
Natera CFO Brophy sells $160k in NTRA stock - Investing.com
Natera CEO Steven Chapman sells $1.15 million in shares - Investing.com
Natera Is Quietly Raising Signatera Pricing Power — Could This Hidden Catalyst Supercharge Revenue Growth? - Smartkarma
Natera (NASDAQ: NTRA) president awarded RSUs, sells shares for tax - Stock Titan
Natera (NTRA) co-founder reports RSU grant and small tax-driven share sale - Stock Titan
Natera (NASDAQ:NTRA) Insider Sells $186,778.95 in Stock - MarketBeat
The Bull Case For Natera (NTRA) Could Change Following 2026 Guidance And New Signatera Bladder Data - simplywall.st
Natera at Leerink Global Healthcare Conference: Strategic Growth and Investment By Investing.com - Investing.com
Natera (NTRA) legal chief exercises 5,598 options and sells 8,398 shares - Stock Titan
Natera Officer Daniel Rabinowitz Sells Shares - TradingView
Healthcare Sector Analysis: Natera, ResMed, Globus Medical Driving InnovationNews and Statistics - IndexBox
3 Healthcare Stocks to Target This Week - Finviz
Evercore ISI Initiates Coverage on Natera (NTRA) with Outperform Rating - MSN
Rhenman & Partners Asset Management AB Reduces Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Bought by Neuberger Berman Group LLC - MarketBeat
Dynamic Technology Lab Private Ltd Acquires New Position in Natera, Inc. $NTRA - MarketBeat
Quantbot Technologies LP Buys Shares of 6,638 Natera, Inc. $NTRA - MarketBeat
Wall Street Zen Upgrades Natera (NASDAQ:NTRA) to "Buy" - MarketBeat
How Natera Inc. stock reacts to inflationary pressuresGlobal Markets & Weekly High Conviction Ideas - Naître et grandir
Morgan Stanley Smith Barney files Form 144 notice (NTRA) listing recent insider sales - Stock Titan
Bear Alert: Can Natera Inc outperform in the next rally2025 EndofYear Setup & Community Verified Swing Trade Signals - baoquankhu1.vn
Natera Inc. Earnings Call Signals Profitable Growth - TipRanks
Assessing Natera (NTRA) Valuation After Earnings Beat And Raised 2026 Guidance - simplywall.st
Fed Meeting: Can Bone Biologics Corporation Equity Warrant generate free cash flowQuarterly Trade Summary & Real-Time Buy Zone Alerts - baoquankhu1.vn
Victory Capital Management Inc. Sells 165,275 Shares of Natera, Inc. $NTRA - MarketBeat
Pura Vida Investments LLC Has $402,000 Stake in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. $NTRA Shares Sold by GW&K Investment Management LLC - MarketBeat
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.10%
0.59%
자본화:
|
볼륨(24시간):